The newly studied SHE was also effective in the regulation of serum IgE concentration, spleen weight, mast cell counts, inflammatory cytokines, and keratinocyte differentiation markers in a mouse model of DNCB-induced AD. This evidence concerns the gene IGHE and Alzheimer disease.